Search Results - "Kotula, P L"

Interleukin-2 activation of chemotherapy and growth factor-mobilized peripheral blood stem cells for generation of cytotoxic effectors by Verma, U N, Areman, E, Dickerson, S A, Kotula, P L, Sacher, R, Mazumder, A

“…Based on our previous studies demonstrating marked anti-tumor activity of interleukin-2 (IL-2)-activated bone marrow in vitro and in vivo, we studied the…”
Get more information

Hematopoietic potential of IL-2-cultured peripheral blood stem cells from breast cancer patients by Areman, E M, Mazumder, A, Kotula, P L, Verma, U N, Rajagopal, C, Hancock, S, Guevarra, C, Djahanmir, M, Sacher, R A, Meehan, K R

“…Patients receiving autologous transplants for various malignancies generally experience an increased incidence of relapse compared with patients receiving…”
Get more information

Use of a licensed electrolyte solution as an alternative to tissue culture medium for bone marrow collection by Areman, E M, Dickerson, S A, Kotula, P L, Spitzer, T R, Sacher, R A

“…Bone marrow for transplantation is traditionally collected into tissue culture medium with heparin. A licensed electrolyte solution (Plasma-Lyte A [PLA]) was…”
Get more information

A novel approach to immunomodulation of frozen human bone marrow with interleukin-2 for clinical application by Charak, B S, Areman, E M, Dickerson, S A, Choudhary, G D, Sacher, R, Kotula, P L, Brown, E G, Mazumdar, A

“…Interleukin-2 (IL-2) activation of fresh or frozen bone marrow (BM) in vitro generates killer cells with potent anti-tumor effect both in vitro and in vivo…”
Get more information

The impact of harvest center on quality of marrows collected from unrelated donors by Spitzer, T R, Areman, E M, Cirenza, E, Yu, M, Dickerson, S, Kotula, P L, Sacher, R A, Cottler-Fox, M

“…The total number and distribution of nucleated cells in harvested bone marrow are potentially important determinants of patient outcome following bone marrow…”
Get more information